The 19 analysts offering 12-month price forecasts for Bristol-Myers Squibb Co have a median target of 80.00, with a high estimate of 94.00 and a low estimate of 63.00. The median estimate represents a +5.07% increase from the last price of 76.14.
The current consensus among 23 polled investment analysts is to Buy stock in Bristol-Myers Squibb Co. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share $1.90
Reporting Date Jul 27
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.